US6790965B1
(en)
|
1994-05-06 |
2004-09-14 |
Pharmacopeia Drug Discovery, Inc. |
Combinatorial dihydrobenzopyran library
|
DE19610103A1
(de)
|
1996-03-15 |
1997-09-18 |
Basf Ag |
Cycloalkylderivate und ihre Synthese an fester Phase
|
DE19621177A1
(de)
|
1996-05-24 |
1997-11-27 |
Basf Ag |
Kohlenhydratderivate und ihre Synthese an fester Phase
|
DE19626762A1
(de)
|
1996-07-03 |
1998-01-08 |
Basf Ag |
Enzymatisch spaltbare Linker für Festphasensynthesen
|
ATE311377T1
(de)
|
1996-08-26 |
2005-12-15 |
Pfizer |
Spirocyclische dopaminrezeptor-subtyp-liganden
|
US5908960A
(en)
*
|
1997-05-07 |
1999-06-01 |
Smithkline Beecham Corporation |
Compounds
|
US6004823A
(en)
*
|
1997-05-07 |
1999-12-21 |
Smithkline Beecham Corporation |
Compounds
|
EP0905512A1
(fr)
*
|
1997-09-25 |
1999-03-31 |
Cerep |
Méthode pour l'identification des structures de base ou composés actifs
|
US6362009B1
(en)
|
1997-11-21 |
2002-03-26 |
Merck & Co., Inc. |
Solid phase synthesis of heterocycles
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US5976813A
(en)
*
|
1997-12-12 |
1999-11-02 |
Abbott Laboratories |
Continuous format high throughput screening
|
CA2352532C
(fr)
|
1998-11-27 |
2014-10-14 |
Darwin Discovery Ltd. |
Compositions et methodes d'augmentation de la mineralisation de la substance osseuse
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
EP1254369B1
(fr)
|
2000-02-08 |
2010-10-06 |
Sangamo BioSciences, Inc. |
Cellules destinees a la decouverte de medicaments
|
US7923542B2
(en)
|
2000-04-28 |
2011-04-12 |
Sangamo Biosciences, Inc. |
Libraries of regulatory sequences, methods of making and using same
|
WO2001084148A2
(fr)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Pharmacogenomique et identification de cibles medicamenteuses par reconstruction des voies de transduction du signal a partir de sequences des regions accessibles
|
GB2365011A
(en)
|
2000-04-28 |
2002-02-13 |
Sangamo Biosciences Inc |
Methods for the characterisation of regulatory DNA sequences
|
WO2001083819A2
(fr)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Procédés d'élaboration de molécules régulatrices exogènes
|
US20020064802A1
(en)
|
2000-04-28 |
2002-05-30 |
Eva Raschke |
Methods for binding an exogenous molecule to cellular chromatin
|
AU6110301A
(en)
|
2000-04-29 |
2001-11-12 |
Univ Iowa Res Found |
Diagnostics and therapeutics for macular degeneration-related disorders
|
AU2001289831A1
(en)
*
|
2000-09-06 |
2002-03-22 |
Bayer Aktiengesellschaft |
Medicaments against viral infections
|
EP2381116A1
(fr)
|
2000-11-16 |
2011-10-26 |
California Institute of Technology |
Appareil et procédés pour effectuer des analyses et criblage à haut rendement
|
WO2002090600A2
(fr)
|
2001-05-08 |
2002-11-14 |
Darwin Molecular Corporation |
Methode de regulation de la fonction immune chez les primates a l'aide de la proteine foxp3
|
US6955888B2
(en)
|
2001-06-11 |
2005-10-18 |
Xenoport |
Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
ATE481422T1
(de)
|
2002-11-21 |
2010-10-15 |
Celltech R & D Inc |
Modulieren von immunantworten
|
US7229617B2
(en)
|
2002-11-27 |
2007-06-12 |
Irm Llc |
Methods and compositions for inducing apoptosis in cancer cells
|
PL378571A1
(pl)
|
2003-02-01 |
2006-05-02 |
Neuralab Limited |
Czynna immunizacja dla wytworzenia przeciwciał przeciw rozpuszczalnemu A-ß
|
WO2004092179A1
(fr)
*
|
2003-04-14 |
2004-10-28 |
Nippon Soda Co. Ltd. |
Derive spiro, procede de production et antioxydant
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
EP2361928B1
(fr)
|
2003-05-19 |
2017-04-26 |
Prothena Biosciences Limited |
Fragments tronqués d'alpha-synucléines dans une maladie de corps de Lewy
|
US8153410B2
(en)
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
AU2004278414B2
(en)
*
|
2003-10-01 |
2012-05-24 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
WO2005043118A2
(fr)
|
2003-10-27 |
2005-05-12 |
Vertex Pharmaceuticals Incorporated |
Methode de decouverte de medicament
|
CN1934127B
(zh)
|
2003-12-17 |
2015-08-19 |
杨森阿尔茨海默氏症免疫治疗公司 |
Αβ免疫原性肽载体-偶联物及其生产方法
|
UA93854C2
(ru)
|
2003-12-17 |
2011-03-25 |
Вайет Ллк |
Иммуногенный конъюгат и способ его получения
|
US7572600B2
(en)
|
2004-08-04 |
2009-08-11 |
Chemocentryx, Inc. |
Enzymatic activities in chemokine-mediated inflammation
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
EP2357254A1
(fr)
|
2005-02-14 |
2011-08-17 |
University of Iowa Research Foundation |
Biomarqueurs associés à la dégénérescence maculaire liée à l'âge
|
ATE509023T1
(de)
|
2005-07-19 |
2011-05-15 |
Merck Sharp & Dohme |
Spirochromanon-derivate als acetyl-koenzym-a- carboxylase-hemmer
|
WO2007030560A2
(fr)
|
2005-09-08 |
2007-03-15 |
Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine |
Identification de modulateurs d'un inhibiteur de serine protease de type kazal et leur utilisation comme agents anticancereux et antiviraux
|
CN101309923A
(zh)
*
|
2005-11-14 |
2008-11-19 |
索尔瓦药物有限公司 |
作为碳酸酐酶抑制剂的n-氨磺酰基-n’-苯并吡喃哌啶
|
AR057570A1
(es)
|
2005-11-14 |
2007-12-05 |
Solvay Pharm Gmbh |
Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
|
EP1996718B1
(fr)
|
2006-03-06 |
2011-11-30 |
Ceetox Inc. |
Procédés de dépistage de la toxicité
|
JP2009538924A
(ja)
|
2006-06-01 |
2009-11-12 |
エラン ファーマシューティカルズ,インコーポレイテッド |
Appの神経活性断片
|
PE20081559A1
(es)
|
2007-01-12 |
2008-11-20 |
Merck & Co Inc |
DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
|
WO2008088692A2
(fr)
|
2007-01-12 |
2008-07-24 |
Merck & Co., Inc. |
Dérivés spirochromanone
|
DK3067066T3
(da)
|
2007-02-23 |
2019-05-20 |
Prothena Biosciences Ltd |
Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
|
PT3067066T
(pt)
|
2007-02-23 |
2019-06-17 |
Univ California |
Prevenção e tratamento da doença sinucleinopática e amiloidogénica
|
US8779088B2
(en)
|
2007-12-17 |
2014-07-15 |
Marfl Ab |
Vaccine for the treatment of Mycobacterium related disorders
|
AU2008345022B2
(en)
|
2007-12-28 |
2014-11-06 |
Prothena Biosciences Limited |
Treatment and prophylaxis of amyloidosis
|
TWI492951B
(zh)
|
2007-12-31 |
2015-07-21 |
Baxter Int |
表現人類凝血因子的基因轉殖非人類動物及其用途
|
WO2009091586A2
(fr)
|
2008-01-18 |
2009-07-23 |
North Carolina State University |
Peptides et méthodes d'utilisation comme agents thérapeutiques et agents de criblage
|
US8524730B2
(en)
|
2008-07-04 |
2013-09-03 |
Msd K.K. |
Spirochromanone carboxylic acids
|
KR101453141B1
(ko)
|
2008-08-18 |
2014-10-23 |
재단법인서울대학교산학협력재단 |
라이실 tRNA 합성효소의 세포내 수준을 조절하여 암 전이 또는 암 세포의 이동을 조절하는 방법
|
NZ594230A
(en)
*
|
2009-03-13 |
2013-11-29 |
Vitae Pharmaceuticals Inc |
Inhibitors of beta-secretase
|
JP6059014B2
(ja)
|
2009-06-19 |
2017-01-11 |
アリゾナ ボード オブ リージェンツ ア ボディー コーポレート アクティング オン ビハーフ オブ アリゾナ ステイト ユニバーシティARIZONA BOARD OF REGENTS,a body corporate acting on behalf of ARIZONA STATE UNIVERSITY |
試料の構成成分の検出において使用されるデバイスを製造する方法およびペプチドアレイ
|
EP2539322B1
(fr)
|
2010-02-24 |
2014-01-01 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs de la bêta-secrétase
|
WO2011140425A1
(fr)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Amides de chromène hétérocyclique-pipéridine spirocyclique utiles comme modulateurs des canaux ioniques
|
DK2670752T3
(en)
|
2011-02-02 |
2016-07-04 |
Vertex Pharma |
PYRROLOPYRAZINE SPIROCYCLIC PIPERIDINAMIDE AS ION CHANNEL MODULATORS
|
JP5940562B2
(ja)
|
2011-02-18 |
2016-06-29 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
イオンチャネルのモジュレーターとしてのクロマン−スピロ環式ピペリジンアミド
|
ES2618929T3
(es)
|
2011-03-14 |
2017-06-22 |
Vertex Pharmaceuticals Incorporated |
Morfolina-Spiro piperidina amida cíclica como moduladores del canal iónico
|
US8975293B2
(en)
|
2011-05-26 |
2015-03-10 |
Regents Of The University Of Michigan |
Epigenetic co-repressors of the gamma-globin gene and methods of using same
|
CN103959058B
(zh)
|
2011-09-22 |
2015-12-09 |
医药生命融合研究团 |
亮氨酰tRNA合成酶的新用途
|
CN103958668A
(zh)
|
2011-09-23 |
2014-07-30 |
路易斯维尔大学研究基金会公司 |
用于扩充细胞及改善嫁接的方法和组合物
|
KR101398079B1
(ko)
|
2011-10-10 |
2014-05-27 |
재단법인 의약바이오컨버젼스연구단 |
글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법
|
WO2013078138A1
(fr)
|
2011-11-21 |
2013-05-30 |
OSI Pharmaceuticals, LLC |
Spectroscopie rmn du proton pour criblage biochimique
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β-分泌酶抑制劑
|
TW201422592A
(zh)
|
2012-08-27 |
2014-06-16 |
Boehringer Ingelheim Int |
β-分泌酶抑制劑
|
EP2900650A1
(fr)
|
2012-09-28 |
2015-08-05 |
Vitae Pharmaceuticals, Inc. |
Inhibiteurs de beta-secrétase
|
US9970932B2
(en)
|
2013-03-15 |
2018-05-15 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Non-covalent patterned chemical features and use thereof in MALDI-based quality control
|
US10006919B2
(en)
|
2013-03-15 |
2018-06-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Peptide array quality control
|
JP6796059B2
(ja)
|
2014-09-12 |
2020-12-02 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Wntシグナリングアゴニスト分子
|
WO2016100857A1
(fr)
|
2014-12-19 |
2016-06-23 |
Regeneron Pharmaceuticals, Inc. |
Cellules souches comme modèle du diabète de type 2
|
US10758886B2
(en)
|
2015-09-14 |
2020-09-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Conditioned surfaces for in situ molecular array synthesis
|
WO2017208210A1
(fr)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anticorps anti-mcam et methodes d'utilisation associées
|
CN109790203A
(zh)
|
2016-06-20 |
2019-05-21 |
健康之语公司 |
自身免疫疾病的诊断和治疗方法
|
EP3472201A4
(fr)
|
2016-06-20 |
2020-05-13 |
Healthtell Inc. |
Procédés pour le diagnostic différentiel de maladies auto-immunes
|
EP3482210B1
(fr)
|
2016-07-06 |
2021-06-23 |
Prothena Biosciences Limited |
Essai pour la détection d'alpha-synucléine totale et phosphorylée sur s129
|
MX2019001211A
(es)
|
2016-07-29 |
2019-09-16 |
Regeneron Pharma |
Ratones que comprenden mutaciones que dan lugar a la expresión de la fibrilina-1 truncada en c.
|
CA3038846A1
(fr)
|
2016-10-12 |
2018-04-19 |
Janssen Biotech, Inc. |
Procedes de criblage de modulateurs d'une activite biologique de type gdf15
|
WO2018089858A1
(fr)
|
2016-11-11 |
2018-05-17 |
Healthtell Inc. |
Procédés pour l'identification de biomarqueurs candidats
|
CA3061429A1
(fr)
|
2017-05-05 |
2018-11-08 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Medicaments ciblant les microtubules en tant qu'inhibiteurs de points de controle immunitaires et procedes de criblage de nouveaux inhibiteurs de points de controle immunitaires p our le traitement de cancers et de maladies infectieuses
|
WO2019055618A1
(fr)
|
2017-09-15 |
2019-03-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Procédés de classification des réponses à une immunothérapie anticancéreuse
|
US20190141966A1
(en)
|
2017-11-10 |
2019-05-16 |
Regeneron Pharmaceuticals, Inc. |
Non-Human Animals Comprising SLC30A8 Mutation And Methods Of Use
|
AU2019304526A1
(en)
|
2018-07-20 |
2020-12-24 |
Aicuris Gmbh & Co. Kg |
Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses
|
CN113966401A
(zh)
|
2019-04-10 |
2022-01-21 |
犹他大学研究基金会 |
用于治疗amd的htra1调节
|
EP4038222A4
(fr)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
Procédés et compositions pour identifier des néo-antigènes destinés à être utilisés dans le traitement et la prévention du cancer
|
WO2022235929A1
(fr)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Modèle animal ayant une recombinaison homologue du récepteur pth1 de souris
|